BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)

SHA:688166 Statistics

Total Valuation

SHA:688166 has a market cap or net worth of CNY 17.30 billion. The enterprise value is 19.12 billion.

Market Cap	17.30B
Enterprise Value	19.12B

Important Dates

The next confirmed earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	Jun 23, 2025

Share Statistics

SHA:688166 has 422.74 million shares outstanding. The number of shares has increased by 2.58% in one year.

Current Share Class	422.74M
Shares Outstanding	422.74M
Shares Change (YoY)	+2.58%
Shares Change (QoQ)	+16.90%
Owned by Insiders (%)	33.75%
Owned by Institutions (%)	16.32%
Float	253.24M

Valuation Ratios

The trailing PE ratio is 308.59.

PE Ratio	308.59
Forward PE	n/a
PS Ratio	14.14
PB Ratio	6.83
P/TBV Ratio	7.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	341.03
EV / Sales	15.62
EV / EBITDA	170.68
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.92
Debt / EBITDA	20.90
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 2.26% and return on invested capital (ROIC) is 0.38%.

Return on Equity (ROE)	2.26%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.38%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.57%
Revenue Per Employee	1.06M
Profits Per Employee	48,702
Employee Count	1,162
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-40.62M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.79% in the last 52 weeks. The beta is 0.17, so SHA:688166's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	+15.79%
50-Day Moving Average	48.33
200-Day Moving Average	63.65
Relative Strength Index (RSI)	30.67
Average Volume (20 Days)	7,302,891

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688166 had revenue of CNY 1.22 billion and earned 56.06 million in profits. Earnings per share was 0.13.

Revenue	1.22B
Gross Profit	1.22B
Operating Income	16.19M
Pretax Income	15.44M
Net Income	56.06M
EBITDA	112.01M
EBIT	16.19M
Earnings Per Share (EPS)	0.13

Balance Sheet

The company has 606.22 million in cash and 2.34 billion in debt, with a net cash position of -1.73 billion or -4.10 per share.

Cash & Cash Equivalents	606.22M
Total Debt	2.34B
Net Cash	-1.73B
Net Cash Per Share	-4.10
Equity (Book Value)	2.53B
Book Value Per Share	6.13
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 1.32% and 4.58%.

Gross Margin	100.00%
Operating Margin	1.32%
Pretax Margin	1.26%
Profit Margin	4.58%
EBITDA Margin	9.15%
EBIT Margin	1.32%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.23%.

Dividend Per Share	0.10
Dividend Yield	0.23%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.58%
Shareholder Yield	-2.34%
Earnings Yield	0.32%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2